Stock listing

Bausch + Lomb Corporation

Selected listing: BLCO · NYSE · USD · US

Bausch + Lomb Corporation (NYSE:BLCO), Health Technology. Latest release Oct 6, 2026: Bausch + Lomb Advances Novel Oral Treatment for Dry AMD Following…

BLCO:NYSEUSDUSUpdated August 31, 2026

Ticker: NYSE:BLCO
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: NYSE
Currency: USD

About Bausch + Lomb Corporation

Bausch + Lomb Corporation, traded under the ticker BLCO, is a public company operating in the American market. Bausch + Lomb is committed to enhancing the quality of life for individuals with vision-related needs.

Latest news from Bausch + Lomb Corporation

Bausch + Lomb Advances Novel Oral Treatment for Dry AMD Following Constructive FDA Meeting

October 6, 2026

Bausch + Lomb Will Release Third-Quarter 2026 Financial Results on Oct. 28

October 5, 2026

Bausch + Lomb Announces European CE Mark Approval of SeeLyra Femtosecond Laser

September 14, 2026

Bausch + Lomb Announces European CE Mark Approval of SeeLyra™ Femtosecond Laser

September 11, 2026

Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience

September 2, 2026

All Bausch + Lomb Corporation news →

Events

Replays

Bausch + Lomb Corporation (BLCO) Q2 2026 Earnings Call
Wed, Jul 29, 2026 · 08:00 AM ET
Watch
Bausch + Lomb Corporation (BLCO) Q1 2026 Earnings Call
Wed, Apr 29, 2026 · 08:00 AM ET
Watch
Bausch + Lomb Corporation (BLCO) Q4 2025 Earnings Call
Wed, Feb 18, 2026 · 08:00 AM ET
Watch

Research Bausch + Lomb Corporation

Bausch + Lomb Corporation company profile

View the public company page for Bausch + Lomb Corporation on 6ix.

Bausch + Lomb Corporation news

Read company news and market updates connected to Bausch + Lomb Corporation.

Bausch + Lomb Corporation investor events

Find investor webinars, events, and replay context for Bausch + Lomb Corporation.